Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Jan 25, 2025. (Total: 235671Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 9 (of 9 Records)

Query Trace: Disease Progression and NPM1[original query]
Screening for hotspot mutations in PI3K, JAK2, FLT3 and NPM1 in patients with myelodysplastic syndromes.
Clinics (São Paulo, Brazil) 2011 66 (5): 793-9.
Machado-Neto João Agostinho, Traina Fabiola, Lazarini Mariana, Campos Paula de Melo, Pagnano Katia Borgia Barbosa, Lorand-Metze Irene, Costa Fernando Ferreira, Saad Sara T Olal
GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution.
Annals of hematology 2015 Feb 94 (2): 211-21.
Hou Hsin-An, Lin Yun-Chu, Kuo Yuan-Yeh, Chou Wen-Chien, Lin Chien-Chin, Liu Chieh-Yu, Chen Chien-Yuan, Lin Liang-In, Tseng Mei-Hsuan, Huang Chi-Fei, Chiang Ying-Chieh, Liu Ming-Chih, Liu Chia-Wen, Tang Jih-Luh, Yao Ming, Huang Shang-Yi, Ko Bor-Sheng, Hsu Szu-Chun, Wu Shang-Ju, Tsay Woei, Chen Yao-Chang, Tien Hwei-Fa
TP53 mutations in de novo acute myeloid leukemia patients: longitudinal follow-ups show the mutation is stable during disease evolution.
Blood cancer journal 2015 5 e331.
Hou H-A, Chou W-C, Kuo Y-Y, Liu C-Y, Lin L-I, Tseng M-H, Chiang Y-C, Liu M-C, Liu C-W, Tang J-L, Yao M, Li C-C, Huang S-Y, Ko B-S, Hsu S-C, Chen C-Y, Lin C-T, Wu S-J, Tsay W, Chen Y-C, Tien H
Cytokine rs361525, rs1800750, rs1800629, rs1800896, rs1800872, rs1800795, rs1800470, and rs2430561 SNPs in relation with prognostic factors in acute myeloid leukemia.
Cancer medicine 2019 Aug .
B?nescu Claudia, Tripon Florin, Trifa Adrian P, Crauciuc Andrei G, Moldovan Valeriu G, Bogli? Alina, Benedek Istvan, Dima Delia, Cândea Marcela, Duicu Carmen, Iancu Mihae
Presence of copy number aberration and clinical prognostic factors in patients with acute myeloid leukemia: an analysis of effect modification.
Polish archives of internal medicine 2019 12 .
Banescu Claudia, Tripon Florin, Trifa Adrian P, Crauciuc Andrei G, Bogli? Alina, Lazar Erzsebet, Dima Delia, Macarie Ioan, Duicu Carmen, Iancu Mihae
Sorafenib and omacetaxine mepesuccinate as a safe and effective treatment for acute myeloid leukemia carrying internal tandem duplication of Fms-like tyrosine kinase 3.
Cancer 2019 10 126 (2): 344-353.
Zhang Chunxiao, Lam Stephen S Y, Leung Garret M K, Tsui Sze-Pui, Yang Ning, Ng Nelson K L, Ip Ho-Wan, Au Chun-Hang, Chan Tsun-Leung, Ma Edmond S K, Yip Sze-Fai, Lee Harold K K, Lau June S M, Luk Tsan-Hei, Li Wa, Kwong Yok-Lam, Leung Anskar Y
Differential U2AF1 mutation sites, burden and co-mutation genes can predict prognosis in patients with myelodysplastic syndrome.
Scientific reports 2020 10 10 (1): 18622.
Wang Haiqiong, Guo Yongbo, Dong Zhenkun, Li Tao, Xie Xinsheng, Wan Dingming, Jiang Zhongxing, Yu Jifeng, Guo Ro
Molecular and clinical significance of FLT3, NPM1, DNMT3A and TP53 mutations in acute myeloid leukemia patients.
Molecular biology reports 2023 8 .
Ayad M Ali, Gaza F Sal
Description of lymphocyte and cytokine profiles in individuals with acute myeloid leukemia associated with FLT3-ITD and NPM1 mutation status.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2024 6 .
Rogério Reis, Gabriel S Müller, Mariane M Santos, Allan S Santos, Herbert Santos, Lorene S Santos, Bruno A Lopes, Soraya C Trindade, Roberto J Meyer, Songelí M Frei
TOP